Richard Payerchin

At the state level, medication treatment rates ranged from 17.7% in Kansas to 82.8% in Maine.

According to commentaries published in the Annals of Internal Medicine, doctors remain split on the question.

Federal regulators need to address potential policy changes that could affect primary care.

As President Biden announces the end of the COVID-19 public health emergency, urgency grows.

Pharmaceutical makers, price managers out of control with ‘necessary drug’ for millions, Attorney General says.

Researchers analyze pandemic mortality, ‘excess deaths,’ along party lines in two states.

A physical medicine specialist describes her experience as a doctor and as a patient, and explains why primary care will be the center for treatment.

Health, science, and politics are in the mix as studies examine links among debates over shots against COVID-19 and measles.

Privacy rules to improve coordination of care, avoid discrimination in treatment.

Study examines patient action that ‘is frequently harmful, and sometimes deadly'.

Pre-pandemic survey examines effects of heart disease, asthma, and more.

Positive effects emerge when patients get medical care, avoid deadly fentanyl-laced street drugs.

Congress could overrule presidential declaration, but White House threatened veto of similar measure in March.

Study finds growth in three years after CDC guideline for primary care clinicians.

Move comes after FDA give emergency use authorization for bivalent vaccines.

Pfizer-BioNTech hopes booster can be available for use this fall.

Domestic production to begin at Michigan-based pharmaceutical maker.

More people getting health coverage, but 26.4 million still don’t have it.

Security gaps in software and regulation compliance were identified.

Fentanyl, COVID-19 pandemic likely factors in 30% increase from previous year.

Study finds growth in three years after CDC guideline for primary care clinicians.

The state's budget includes $100 million for the new program.

Purchase follows FDA recommendation to include Omicron component in boosters.

Ruling comes in cases with prison sentences for convictions over prescription drugs.

Medical groups praise decision, but e-cigarette maker could return to U.S. market.

New medical guidance notes market booms as Americans seek good health in pills.

Proposal follows announced ban on menthol cigarettes, flavored cigars, and e-cig ban could be coming.

Rising insulin prices have led department to examine the impetus behind setting prices that many patients can't afford.

The move is latest step in retail, telehealth, venture capital competition with physicians.

Patients may use drugs for reasons or time frame other than intended by prescriber, according to study.